The significant miss in both earnings and sales expectations for CollPlant Biotechnologies is likely to negatively impact investor sentiment in the short term. The magnitude of the miss, especially in sales which were 96.51% below the estimate, indicates potential underlying issues that could concern investors. Despite the year-over-year increase in sales, the failure to meet analyst expectations by such a wide margin could lead to a decrease in stock price.